BioPharm - Sierra

You have been chosen to receive this valuable information.

Tuesday, May 19, 2020 | 11:00 -11:30 am EST

USP Biologics is pleased to kick off a series of webinars to keep you up-to-date on current trends, USP initiatives and opportunities for stakeholders to impact public health standards. Each webinar will be hosted live with student interaction and will be posted for on-demand viewing later.

This first webinar will share some of the needs we’ve uncovered and the lessons we’ve learned as a result of our public outreach on COVID-19. In addition, USP standards that support vaccine development and monoclonal antibody characterization will be reviewed along with tools supporting this work.

By taking this course, you will be able to:

Describe trends and needs for future COVID-19 innovation
Identify USP standards that support development and characterization of vaccines and monoclonal antibodies
Identify USP staff and resources that can support analytical method development and validation for COVID-19 therapeutics, vaccines and related biologics

USP Approved
Instructor

Dr. Fouad Atouf
Vice President, USP
Global Biologics

Of possible interest..

Phase-Appropriate CMC Development For Synthetic Peptides
(On-Demand)

Therapeutic Oligonucleotides Production: CMC – Regulatory – Quality
(On-Demand)

Qualification of Raw Materials and Cell Substrates for Biomanufacturing
(On-Demand)

For more information on other course offerings–

Email:
education@usp.org
Website:
education.usp.org

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of BioPharm, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.